{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:58:17Z","timestamp":1792659497191,"version":"4.5.0"},"reference-count":97,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>SLE is a chronic inflammatory disease that affects the kidneys in about 50% of patients. Lupus nephritis is a major risk factor for overall morbidity and mortality in SLE, and despite potent anti-inflammatory and immunosuppressive therapies still ends in CKD or ESRD for too many patients. This review highlights recent updates in our understanding of disease epidemiology, genetics, pathogenesis, and treatment in an effort to establish a framework for lupus nephritis management that is patient-specific and oriented toward maintaining long-term kidney function in patients with lupus.<\/jats:p>","DOI":"10.2215\/cjn.05780616","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T22:14:03Z","timestamp":1478556843000},"page":"825-835","source":"Crossref","is-referenced-by-count":797,"title":["Update on Lupus Nephritis"],"prefix":"10.2215","volume":"12","author":[{"given":"Salem","family":"Almaani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Meara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H.","family":"Rovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"604892","DOI":"10.1155\/2012\/604892","article-title":"Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis","volume":"2012","author":"Schwartzman-Morris","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","article-title":"Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden","volume":"15","author":"Danchenko","year":"2006","journal-title":"Lupus"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rdc.2009.12.012","article-title":"Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?","volume":"36","author":"Mina","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/0961203310374305","article-title":"Epidemiology of systemic lupus erythematosus in Asia","volume":"19","author":"Osio-Salido","year":"2010","journal-title":"Lupus"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/096120339500400303","article-title":"Frequency of lupus in people of African origin","volume":"4","author":"Symmons","year":"1995","journal-title":"Lupus"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0961203313509296","article-title":"Lupus in Africa: can we dispel the myths and face the challenges?","volume":"23","author":"Tiffin","year":"2014","journal-title":"Lupus"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","article-title":"Understanding the epidemiology and progression of systemic lupus erythematosus","volume":"39","author":"Pons-Estel","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1191\/0961203302lu158oa","article-title":"Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis","volume":"11","author":"Bastian","year":"2002","journal-title":"Lupus"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","article-title":"The frequency and outcome of lupus nephritis: results from an international inception cohort study","volume":"55","author":"Hanly","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1038\/sj.ki.5000243","article-title":"Outcomes in African Americans and Hispanics with lupus nephritis","volume":"69","author":"Contreras","year":"2006","journal-title":"Kidney Int"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2215\/CJN.11261114","article-title":"Patient characteristics and outcomes by GN subtype in ESRD","volume":"10","author":"O\u2019Shaughnessy","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.59.2.116","article-title":"Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus","volume":"59","author":"Hopkinson","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005792-199905000-00002","article-title":"Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center","volume":"78","author":"Huong","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0961203314567753","article-title":"Lupus in Latin-American patients: lessons from the GLADEL cohort","volume":"24","author":"Pons-Estel","year":"2015","journal-title":"Lupus"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/ard.2010.131482","article-title":"US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: Data from LUMINA, a multiethnic US cohort (LUMINA LXXIV)","volume":"70","author":"Burgos","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/j.ajkd.2015.04.011","article-title":"Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE","volume":"66","author":"Nee","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B18-20230813","first-page":"1620","article-title":"High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients","volume":"10","author":"Austin","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K","article-title":"Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture","volume":"41","author":"Reveille","year":"1998","journal-title":"Arthritis Rheum"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1172\/JCI118552","article-title":"Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans","volume":"97","author":"Salmon","year":"1996","journal-title":"J Clin Invest"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2006090992","article-title":"Severe lupus nephritis: racial differences in presentation and outcome","volume":"18","author":"Korbet","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/gene.2011.82","article-title":"Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis","volume":"13","author":"Lin","year":"2012","journal-title":"Genes Immun"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/rheumatology\/kel347","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria","volume":"46","author":"Bastian","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/art.1780361110","article-title":"A distinctive autoantibody profile in black female patients with lupus nephritis","volume":"36","author":"McCarty","year":"1993","journal-title":"Arthritis Rheum"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reuma.2010.11.001","article-title":"Multiethnic lupus cohorts: what have they taught us?","volume":"7","author":"Alarc\u00f3n","year":"2011","journal-title":"Reumatol Clin"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.39594","article-title":"Risk of end-stage renal disease in patients with lupus nephritis, 1970-2015: A systematic review and Bayesian meta-analysis","volume":"68","author":"Tektonidou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1093\/ndt\/gfs073","article-title":"Survival analysis and causes of mortality in patients with lupus nephritis","volume":"27","author":"Yap","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1177\/0961203314551083","article-title":"Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study","volume":"23","author":"Lerang","year":"2014","journal-title":"Lupus"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/acr.20116","article-title":"Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis","volume":"62","author":"Faurschou","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2215\/CJN.03280807","article-title":"Value of a complete or partial remission in severe lupus nephritis","volume":"3","author":"Chen","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semnephrol.2015.08.002","article-title":"Genetics of Lupus Nephritis: Clinical Implications","volume":"35","author":"Munroe","year":"2015","journal-title":"Semin Nephrol"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/1756-185X.12528","article-title":"Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis","volume":"18","author":"Niu","year":"2015","journal-title":"Int J Rheum Dis"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI74961","article-title":"Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA","volume":"125","author":"Miyadera","year":"2015","journal-title":"J Clin Invest"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/jhg.2015.100","article-title":"Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism","volume":"60","author":"Miyadera","year":"2015","journal-title":"J Hum Genet"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1681\/ASN.2013050446","article-title":"Lupus nephritis susceptibility loci in women with systemic lupus erythematosus","volume":"25","author":"Chung","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"e1005487","DOI":"10.1371\/journal.pgen.1005487","article-title":"Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality","volume":"11","author":"Raffler","year":"2015","journal-title":"PLoS Genet"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1399-0039.2007.00975.x","article-title":"The sodium-dependent glucose cotransporter SLC5A11 as an autoimmune modifier gene in SLE","volume":"71","author":"Tsai","year":"2008","journal-title":"Tissue Antigens"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","article-title":"Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients","volume":"165","author":"Banchereau","year":"2016","journal-title":"Cell"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"B42-20230813","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.03990415","article-title":"Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare","volume":"11","author":"Birmingham","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B44-20230813","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.imbio.2014.07.004","article-title":"Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro","volume":"219","author":"Pang","year":"2014","journal-title":"Immunobiology"},{"key":"B45-20230813","first-page":"23","article-title":"Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus","volume":"75","author":"Gargiulo","year":"2015","journal-title":"Medicina (B Aires)"},{"key":"B46-20230813","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"key":"B47-20230813","first-page":"332","article-title":"Renal biopsy in lupus patients with low levels of proteinuria","volume":"34","author":"Christopher-Stine","year":"2007","journal-title":"J Rheumatol"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/ard.62.5.435","article-title":"Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment","volume":"62","author":"Fiehn","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneph.2009.130","article-title":"Glomerular disease: Lupus nephritis treatment: are we beyond cyclophosphamide?","volume":"5","author":"Rovin","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B51-20230813","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2215\/CJN.06720615","article-title":"Clinical-Morphological Features and Outcomes of Lupus Podocytopathy","volume":"11","author":"Hu","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B52-20230813","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0272-6386(96)90553-3","article-title":"Predominant tubulointerstitial lupus nephritis","volume":"27","author":"Singh","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"B53-20230813","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B54-20230813","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI200419139","article-title":"Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli","volume":"113","author":"Peterson","year":"2004","journal-title":"J Clin Invest"},{"key":"B55-20230813","doi-asserted-by":"crossref","first-page":"e77489","DOI":"10.1371\/journal.pone.0077489","article-title":"Comparative transcriptional profiling of 3 murine models of SLE nephritis reveals both unique and shared regulatory networks","volume":"8","author":"Bethunaickan","year":"2013","journal-title":"PLoS One"},{"key":"B56-20230813","doi-asserted-by":"crossref","first-page":"e000112","DOI":"10.1136\/lupus-2015-000112","article-title":"Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders","volume":"2","author":"Parikh","year":"2015","journal-title":"Lupus Sci Med"},{"key":"B57-20230813","article-title":"Histologic versus clinical remission in proliferative lupus nephritis [published online ahead of print August 6, 2015]","author":"Malvar","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B58-20230813","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1136\/lupus-2014-000018","article-title":"Role of early repeated renal biopsies in lupus nephritis","volume":"1","author":"Zickert","year":"2014","journal-title":"Lupus Sci Med"},{"key":"B59-20230813","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203313518625","article-title":"The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients","volume":"23","author":"Alvarado","year":"2014","journal-title":"Lupus"},{"key":"B60-20230813","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"B61-20230813","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.semnephrol.2015.08.008","article-title":"The Kidney Biopsy in Lupus Nephritis: Past, Present, and Future","volume":"35","author":"Parikh","year":"2015","journal-title":"Semin Nephrol"},{"key":"B62-20230813","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","article-title":"Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages","volume":"59","author":"Hill","year":"2001","journal-title":"Kidney Int"},{"key":"B63-20230813","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1046\/j.1523-1755.2000.00272.x","article-title":"A new morphologic index for the evaluation of renal biopsies in lupus nephritis","volume":"58","author":"Hill","year":"2000","journal-title":"Kidney Int"},{"key":"B64-20230813","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","article-title":"Prognostic factors in lupus nephritis. Contribution of renal histologic data","volume":"75","author":"Austin","year":"1983","journal-title":"Am J Med"},{"key":"B65-20230813","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfr517","article-title":"Strategy for second kidney biopsy in patients with lupus nephritis","volume":"27","author":"Alsuwaida","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B66-20230813","first-page":"2822","article-title":"Serial renal biopsy in systemic lupus erythematosus","volume":"27","author":"Bajaj","year":"2000","journal-title":"J Rheumatol"},{"key":"B67-20230813","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1093\/ndt\/gfp359","article-title":"The clinical relevance of a repeat biopsy in lupus nephritis flares","volume":"24","author":"Daleboudt","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B68-20230813","doi-asserted-by":"crossref","first-page":"e000004","DOI":"10.1136\/lupus-2013-000004","article-title":"Value of repeat biopsy in lupus nephritis flares","volume":"1","author":"Greloni","year":"2014","journal-title":"Lupus Sci Med"},{"key":"B69-20230813","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0272-6386(99)70082-X","article-title":"Clinical and prognostic value of serial renal biopsies in lupus nephritis","volume":"34","author":"Moroni","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"B70-20230813","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1093\/ndt\/gft272","article-title":"The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients","volume":"28","author":"Pagni","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B71-20230813","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.me.31.020180.002335","article-title":"The natural history and response to therapy of lupus nephritis","volume":"31","author":"Ginzler","year":"1980","journal-title":"Annu Rev Med"},{"key":"B72-20230813","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.30293","article-title":"Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006","volume":"63","author":"Costenbader","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B73-20230813","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B74-20230813","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B75-20230813","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B76-20230813","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.05040513","article-title":"Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis","volume":"9","author":"Parikh","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B77-20230813","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N Engl J Med"},{"key":"B78-20230813","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.2008.102533","article-title":"The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide","volume":"69","author":"Houssiau","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B80-20230813","doi-asserted-by":"crossref","first-page":"e000089","DOI":"10.1136\/lupus-2015-000089","article-title":"Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome","volume":"2","author":"Dall\u2019Era","year":"2015","journal-title":"Lupus Sci Med"},{"key":"B81-20230813","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"key":"B82-20230813","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38790","article-title":"Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study","volume":"66","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B83-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40697-014-0030-9","article-title":"The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial","volume":"1","author":"Galbraith","year":"2014","journal-title":"Can J Kidney Health Dis"},{"key":"B84-20230813","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.semnephrol.2013.08.008","article-title":"Complement regulation in renal disease models","volume":"33","author":"Naik","year":"2013","journal-title":"Semin Nephrol"},{"key":"B85-20230813","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2013020143","article-title":"C5a receptor (CD88) blockade protects against MPO-ANCA GN","volume":"25","author":"Xiao","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B86-20230813","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/039139889001300208","article-title":"Complement activated leucopenia during hemodialysis: effect of pulse methyl-prednisolone","volume":"13","author":"Enia","year":"1990","journal-title":"Int J Artif Organs"},{"key":"B87-20230813","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00415-014-7264-4","article-title":"A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis","volume":"261","author":"Vollmer","year":"2014","journal-title":"J Neurol"},{"key":"B88-20230813","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.38259","article-title":"Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells","volume":"66","author":"Louren\u00e7o","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B90-20230813","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7754\/Clin.Lab.2012.120215","article-title":"Bortezomib modulates regulatory T cell subpopulations in the process of acute graft-versus-host disease","volume":"59","author":"Weng","year":"2013","journal-title":"Clin Lab"},{"key":"B91-20230813","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0961203312465781","article-title":"Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE","volume":"22","author":"Dooley","year":"2013","journal-title":"Lupus"},{"key":"B92-20230813","doi-asserted-by":"crossref","DOI":"10.1177\/0961203316650734","article-title":"The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials [published online ahead of print, may 24, 2016]","author":"Rovin","year":"2016","journal-title":"Lupus"},{"key":"B93-20230813","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4049\/jimmunol.0801607","article-title":"Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen","volume":"183","author":"Gallagher","year":"2009","journal-title":"J Immunol"},{"key":"B94-20230813","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"B95-20230813","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smim.2011.01.009","article-title":"The type I interferon system in the development of lupus","volume":"23","author":"R\u00f6nnblom","year":"2011","journal-title":"Semin Immunol"},{"key":"B96-20230813","doi-asserted-by":"crossref","first-page":"e31465","DOI":"10.1371\/journal.pone.0031465","article-title":"Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of na\u00efve T cells into cytokine-producing mature T cells","volume":"7","author":"Tsuda","year":"2012","journal-title":"PLoS One"},{"key":"B97-20230813","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/M14-1030","article-title":"Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized Trial","volume":"162","author":"Liu","year":"2015","journal-title":"Ann Intern Med"},{"key":"B98-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2014-206456","article-title":"Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up","volume":"75","author":"Mok","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B99-20230813","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/acr.20683","article-title":"Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality","volume":"64","author":"Jakes","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201705000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:36:21Z","timestamp":1786368981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201705000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,7]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.05780616","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,7]]}}}